Evidence map›Paper›PMID 20298729›Full record

ReviewAdvanced drug delivery reviews2010

Silk-based delivery systems of bioactive molecules.

Keiji Numata, David L Kaplan

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. High-yield spidroin mimics for bioinspired fibers via computational design.Frontiers in bioengineering and biotechnology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Enhanced Osteogenic Potential ofACS biomaterials science & engineering · 2023
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Keiji NumataDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
David L Kaplan

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
Silica-protein Nanocomposites for Dental RepairR01DE017207 · NIDCR · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2007 to 2016
$3.0M
Silk ScaffoldsR01EB003210 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2003 to 2010
$2.5M
NIBIB NIH HHS P41 EB002520NIBIB NIH HHS R01 EB003210NIDCR NIH HHS R01 DE017207
6 · The paper itself

Abstract

Silks are biodegradable, biocompatible, self-assembling proteins that can also be tailored via genetic engineering to contain specific chemical features, offering utility for drug and gene delivery. Silkworm silk has been used in biomedical sutures for decades and has recently achieved Food and Drug Administration approval for expanded biomaterials device utility. With the diversity and control of size, structure and chemistry, modified or recombinant silk proteins can be designed and utilized in various biomedical application, such as for the delivery of bioactive molecules. This review focuses on the biosynthesis and applications of silk-based multi-block copolymer systems and related silk protein drug delivery systems. The utility of these systems for the delivery of small molecule drugs, proteins and genes is reviewed.

Indexed as

Biocompatible MaterialsBiopolymersDrug Delivery SystemsFibroinsFibronectinsHumansRecombinant Fusion ProteinsRecombinant ProteinsSilkBiocompatible MaterialsBiopolymersFibroinsFibronectinsRecombinant Fusion ProteinsRecombinant ProteinsSilksilk-like protein polymer

Identifiers

PMID20298729
PMCPMC2901564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.